IDEXX Labs (IDXX) Tops Q2 EPS by 10c, Beats on Revenues; Offers FY17 EPS / Revenue Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
IDEXX (IDXX) Oversold, Buy on Weakness - Stifel
August 1, 2017 12:31 PM EDTStifel analyst Jonathan Block sees shares of IDEXX Laboratories (NASDAQ: IDXX) as oversold and reiterated a Buy rating and price target of $185.
Block called the quarter "solid" with a raised outlook but notes shares are under pressure as the magnitude of the beat and... More
CL King Upgrades IDEXX Laboratories (IDXX) to Buy
July 28, 2017 9:26 AM EDTCL King upgraded IDEXX Laboratories (NASDAQ: IDXX) from Neutral to Buy with a price target of $200.00.
For an analyst ratings summary and ratings history on IDEXX Laboratories click here. For more ratings news on IDEXX Laboratories click here.
Shares of IDEXX Laboratories closed at $164.40 yesterday.
... More


